Yachun Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yachun Zhou has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Liang Yang
Southern University of Science and Technology
3 shared publications Anmin Ren
Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, PR China
1 shared publication- Anmin Ren
Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China
1 shared publication - Ashao Jia
Department of Laboratory Medicine, Shenzhen University General Hospital, Shenzhen 518000, China
1 shared publication - Junfeng Wang
State Key Laboratory of Tropical Oceanography/Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou 510301, China
1 shared publication Lei Lei
Baoan Center for Disease Control and Prevention of Shenzhen, Shenzhen 518100, PR China
1 shared publication
Latest Publications
- Open Access
- 9 September 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (9) , 1996
Catheter-Associated Soft Tissue Infection Caused by Pantoea piersonii in a Totally Implantable Venous Access Port: The First Report from China
Pantoea piersonii (formerly Kalamiella piersonii) is a recently reclassified environmental Gram-negative bacterium belonging to the family Erwiniaceae. Human infections caused by this organism are extremely rare. Here, we report a rare case of implantable venous access port-associated soft tissue infection caused by P. piersonii in a 49-year-old immunocompromised woman with lung cancer. The pathogen was isolated from purulent discharge obtained from the port site and identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Whole-genome sequencing confirmed species-level identification based on average nucleotide identity (ANI) analysis and phylogenomic reconstruction. The isolate exhibited broad antimicrobial susceptibility to the tested agents. Following complete device removal and empirical antimicrobial therapy, the patient recovered uneventfully. This study reports the first documented case of P. piersonii infection in China and provides a comprehensive clinical and genomic characterization of a newly isolated clinical strain.
- 9 September 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (9) , 1996
Open AccessCatheter-Associated Soft Tissue Infection Caused by Pantoea piersonii in a Totally Implantable Venous Access Port: The First Report from China
Pantoea piersonii (formerly Kalamiella piersonii) is a recently reclassified environmental Gram-negative bacterium belonging to the family Erwiniaceae. Human infections caused by this organism are extremely rare. Here, we report a rare case of implantable venous access port-associated soft tissue infection caused by P. piersonii in a 49-year-old immunocompromised woman with lung cancer. The pathogen was isolated from purulent discharge obtained from the port site and identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Whole-genome sequencing confirmed species-level identification based on average nucleotide identity (ANI) analysis and phylogenomic reconstruction. The isolate exhibited broad antimicrobial susceptibility to the tested agents. Following complete device removal and empirical antimicrobial therapy, the patient recovered uneventfully. This study reports the first documented case of P. piersonii infection in China and provides a comprehensive clinical and genomic characterization of a newly isolated clinical strain.
- 26 May 2026
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 513, 142491
Bongkrekic acid reprograms hepatic lipid metabolism to promote systemic organ injury
- 26 May 2026
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 513, 142491
Bongkrekic acid reprograms hepatic lipid metabolism to promote systemic organ injury
- Open Access
- 28 October 2024
- Published by MDPI AG in Marine Drugs
- Vol. 22 (11) , 484
New 24-Membered Macrolactines from an Arctic Bacterium Bacillus amyloliquefaciens SCSIO 41392 and Their Anti-Pathogenicity Evaluation
Three new 24-membered macrolactines, amylomacrolactines A–C (1–3), along with two known compounds 4 and 5, were isolated from the Arctic bacteria Bacillus amyloliquefaciens SCSIO 41392. The configurations of 1–3 were assigned by a combination of coupling constants, NOESY, and analysis of MM2-optimized conformation, as well as by comparison with reports in the literature. Compounds 1 and 2 showed quorum sensing (QS) inhibitory activities against the Pseudomonas aeruginosa (P. aeruginosa) PQS system and suppressed PQS-regulated virulence factor pyocyanin synthesis. In addition, compounds 3–5 affected the production of another essential virulence factor, siderophore of pyoverdine (PVD), in P. aeruginosa. More importantly, compound 5 showed an anti-biofilm activity against P. aeruginosa. Altogether, the isolated compounds displayed multiple bacterial virulence inhibition activities, which is worthy of further exploration for novel analogues in antimicrobial drug development.
- 28 October 2024
- Published by MDPI AG in Marine Drugs
- Vol. 22 (11) , 484
Open AccessNew 24-Membered Macrolactines from an Arctic Bacterium Bacillus amyloliquefaciens SCSIO 41392 and Their Anti-Pathogenicity Evaluation
Three new 24-membered macrolactines, amylomacrolactines A–C (1–3), along with two known compounds 4 and 5, were isolated from the Arctic bacteria Bacillus amyloliquefaciens SCSIO 41392. The configurations of 1–3 were assigned by a combination of coupling constants, NOESY, and analysis of MM2-optimized conformation, as well as by comparison with reports in the literature. Compounds 1 and 2 showed quorum sensing (QS) inhibitory activities against the Pseudomonas aeruginosa (P. aeruginosa) PQS system and suppressed PQS-regulated virulence factor pyocyanin synthesis. In addition, compounds 3–5 affected the production of another essential virulence factor, siderophore of pyoverdine (PVD), in P. aeruginosa. More importantly, compound 5 showed an anti-biofilm activity against P. aeruginosa. Altogether, the isolated compounds displayed multiple bacterial virulence inhibition activities, which is worthy of further exploration for novel analogues in antimicrobial drug development.